Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
IMVERSE
Swaziland
- Plan-les-Ouates, Geneva
- 28/06/2022
- Series A
- $4,800,000
Real-time capture, editing and streaming of 3D Holograms for Live Telepresence and Volumetric Content.
We all know that the digital future is 3D. The digital future is streamed LIVE. The digital future is SOCIAL. Our vision is to make it happen NOW.
We are building the future of live 3D telepresence and real-time 3D graphics, powered by our proprietary voxel (volumetric pixel) rendering and simulation engine.
We firmly believe that voxels will become the new 3D graphics representation standard and we aim to pioneer this technological revolution.
The scope is vast with applications across multiple Telepresence verticals - from Remote Work, Training and Collaboration, Online Education to Telehealth, Art, Gaming and Live Entertainment.
Yet we do not build products or create content. We are technologists enabling others to augment existing products, services and applications and to build exciting new ones.
Contact: info@imverse.ch
- Industry Software Development
- Website https://www.imverse.com/
- LinkedIn https://www.linkedin.com/company/imverse3d/
Related People
Javier Bello RuizCo Founder
Switzerland -
Geneva, Geneva,
Research and development of brand new Human Computer Interaction and Mixed Reality technologies for their applications in daily life. Interested in interactive architecture, education technologies, immersive interaction design, cognitive neuroscience and the augmented body.
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)